July 6th, 2011 by admin in Health Policy, Opinion
No Comments »
America’s ICUs are in crisis. Consider these staggering statistics: Today’s ICUs Serve 4 million patients annually, with roughly 20 percent mortality rates among those treated. On average, every patient admitted to the ICU suffers 1.7 potentially life threatening errors every day and estimates show that patients only receive half of the therapies that they should. And 50,000 patients annually die in the ICU from preventable deaths.
But research indicates that ICU patients have lower risks of death and shorter ICU and hospital stays when an intensivist is on duty in the ICU and oversees patient care. The mortality reduction has ranged from 15 to 60 percent lower than in ICUs where there are no intensivists. However, the Committee for Manpower for Pulmonary and Critical Care Services predicts a shortage of 10,000 ICU physicians, called intensivists, who have extra training to specialize in the care of the ICU patient. This national shortage of intensivists makes it extremely difficult to find intensivists that can provide 24/7 care for today’s ICU patients.
The answer to solving this crisis has emerged from the world of telemedicine. Read more »
*This blog post was originally published at Medgadget*
July 6th, 2011 by Paul Auerbach, M.D. in Health Tips
No Comments »
Nasal irrigation is sometimes recommended to thin or remove mucous from the nose. The two most common conditions that produce mucous are upper respiratory infections (e.g., the “common cold”) and allergies. Irrigation may also be beneficial to clear out dust, dirt, and allergens, and to allow the cilia within the nose to function more efficiently. Cilia are organelles that work to move mucous and debris in the nose (among other parts of the body) to a location where they can be expelled more easily. Another benefit of nasal irrigation is that it moisturizes the mucous membranes inside the nose.
Methods of Nasal Irrigation
Irrigation can be pulsatile or non-pulsatile (sometimes called “laminar flow”). Each type has its advocates. It is generally felt to be a safe practice so long as Read more »
This post, Everything You Wanted To Know About Nasal Irrigation, was originally published on
Healthine.com by Paul Auerbach, M.D..
July 5th, 2011 by admin in News
1 Comment »
A strong abdominal exam is a must-have clinical skill for an aspiring healthcare professional. Diagnoses spanning cirrhosis, appendicitis, hernias, peritonitis, aortic aneurysms, and cholecystitis, for example, can be suspected and even made via abdominal exam.
Unfortunately, secondary to factors which include an increasing dependence on imaging and other diagnostics, time constraints in the practice of medicine, and fewer chances for bedside instruction in medical education with work-hour regulations, physicians rely increasingly less on their physical exam skills today than has been the case in the past.
In that manner, here we review the Answers in Abdominal Examination App, released in May 2011 by Answers in Medicine. Answers in Medicine, which specializes in presenting medical content via short modules in audio or video format for healthcare professionals, has developed a number of medical apps, including Answers in Alcoholic Liver Disease, Answers in Ulcerative Colitis, Answers in Crohn’s Disease, Answers in Irritable Bowel Syndrome, and Answers in Dyspepsia, to name several. Read more »
*This blog post was originally published at iMedicalApps*
July 5th, 2011 by David H. Gorski, M.D., Ph.D. in Health Policy, Opinion, Quackery Exposed
No Comments »
The weakness and ineffectiveness of the law in the U.S. regulating dietary supplements has been a frequent topic here on Science-Based Medicine, including the continued failure of efforts to address the serious shortcomings of current law and the illogic at its very heart. Indeed, over the last decade or so that I’ve paid attention to relevant issues regarding supplements continually amazed at how much supplement manufacturers can get away with and for how long. For example, one of the most recent atrocities against science occurred when Boyd Haley, disgraced chemistry professor at the University of Kentucky and prominent member of the mercury militia wing of the anti-vaccine movement, tried to sell an industrial chelator as a dietary supplement to treat autistic children. True, that was too much even for the underfunded, undermanned FDA to ignore, but it was amazing how long he got away with it. Apparently it takes someone trying to market a chemical compound that can’t by any stretch of the imagination be characterized as a “nutrient” or “food” to be so obviously against even the travesty of a mockery of a sham of a law regulating supplements (the Dietary Supplement Health and Education Act of 1994, or the DSHEA) that the FDA could take action.
Of course, here at SBM, we’ve written numerous posts on the shortcomings of the DSHEA. Basically, this law created a new class of regulated entities known as dietary supplements and liberalized the sorts of information that supplement manufacturers could transmit to the public. The result has been this:
It [the DSHEA] also expanded the types of products that could be marketed as “supplements.” The most logical definition of “dietary supplement” would be something that supplies one or more essential nutrients missing from the diet. DSHEA went far beyond this to include vitamins; minerals; herbs or other botanicals; amino acids; other dietary substances to supplement the diet by increasing dietary intake; and any concentrate, metabolite, constituent, extract, or combination of any such ingredients. Although many such products (particularly herbs) are marketed for their alleged preventive or therapeutic effects, the 1994 law has made it difficult or impossible for the FDA to regulate them as drugs. Since its passage, even hormones, such as DHEA and melatonin, are being hawked as supplements.
One might wonder how such a bad law could survive for so long (seventeen years now), but it has its defenders. One man, in particular, defends the DSHEA against all regulatory threats, Read more »
*This blog post was originally published at Science-Based Medicine*
July 5th, 2011 by GarySchwitzer in News, Research
No Comments »
The Spine Journal has published a special June issue focusing on Medtronic’s INFUSE product, or rhBMP-2, a bone growth product commonly used in spine fusion surgeries. A journal news release states:
A critical review of 13 industry-sponsored studies on a spine surgery product found that the actual risk of adverse events was 10 to 50 times the estimates originally reported. The product in question is recombinant bone morphogenetic protein-2 (rhBMP-2), a controversial synthetic bone growth factor often used as a bone graft substitute in spine fusion surgeries. This eye-opening study, “A critical review of rhBMP-2 trials in spinal surgery: emerging safety concerns and lessons learned” is included in a special BMP-focused issue of The Spine Journal.
The comprehensive review found four main areas of concern among the 13 original industry-sponsored studies:
• Conflicts of interest were either not reported or were unclear in each study. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
